Day: January 17, 2024

CPR Cell Phone Repair is delighted to announce the opening of a new store, CPR Cell Phone Repair Laurel, in Laurel, Maryland. This store, owned by Malav Patel, extends CPR’s footprint in Maryland, offering top-tier electronic repair services to the Laurel community.

LAUREL, MD / ACCESSWIRE / January 17, 2024 / CPR Cell Phone Repair, a leader in the electronics repair industry, is proud to announce the opening of a new store, CPR Cell Phone Repair Laurel, located at 14440 Cherry Lane Ct, Suite 115, Laurel, MD, 20707. Under the ownership of Malav Patel, the store is set to offer a comprehensive range of repair services for electronics such as cell phones, laptops, gaming systems, digital music players, tablets, and other personal electronic devices.

CPR Laurel provides the local community with expert repair services for common issues like cracked screens, battery replacements, software malfunctions, and more complex technical repairs. The store’s team of skilled technicians is committed to offering efficient, reliable, and quality repair solutions synonymous with the CPR brand.

"I am excited to bring CPR’s trusted and professional repair services to the people of Laurel," said Malav Patel, owner of CPR Cell Phone Repair Laurel. "Our focus is on delivering exceptional customer service and high-quality repairs, ensuring our customers have access to convenient and reliable electronic repair solutions."

CPR Laurel operates from Monday to Saturday, 10:00 AM to 7:00 PM. Customers can reach the store for inquiries or to schedule a repair at 301-830-1897 or via email at laurel@cpr-stores.com. More information about the services offered can be found on the store’s website at https://www.cellphonerepair.com/laurel-md/.

About CPR Cell Phone Repair

CPR by Assurant (CPR), ranked the no. 1 franchise for electronics repairs in Entrepreneur magazine’s Franchise 500, is one of the largest, fastest-growing mobile repair franchises in North America, operating over 500 locations internationally. As a pioneer and leader in the electronics repair industry, CPR offers same-day repair and refurbishing services for cell phones, laptops, gaming systems, digital music players, tablets, and other personal electronic devices. Founded in Orlando, Fla. in 1996, CPR is owned by Assurant, Inc. (NYSE: AIZ). For more information about CPR by Assurant, visit www.cellphonerepair.com.

Media Contact

Chris Jourdan
chris.jourdan@cpr-corporate.com
877-392-6278 ext. 7711

SOURCE: CPR Cell Phone Repair

View the original press release on accesswire.com

VANCOUVER, BC / ACCESSWIRE / January 17, 2024 / Guanajuato Silver Company Ltd. (the "Company" or "GSilver") (TSXV:GSVR)(OTCQX:GSVRF) is pleased to announce commencement of a relationship with a Mexican silver mining company to process a portion of its surface inventory of mineralized material at Guanajuato Silver’s wholly owned El Cubo mines complex located in Guanajuato, Mexico.

Guanajuato Silver’s Chairman & CEO, James Anderson said, "We are excited to have reached this agreement which will utilize a considerable amount of the excess capacity that exists at our El Cubo mill. We believe both parties will mutually benefit from this agreement, as we collectively look to expand silver production in the Guanajuato area through the processing of low-cost and readily available material. With additional unutilized capacity still available at El Cubo, we continue to pursue similar business agreements with other mining groups in the area."

This material has been demonstrated compatible with the El Cubo processing circuit through comprehensive metallurgical testing; the first silver and gold concentrates from this processing agreement are expected to be generated prior to the end of January 2024.

About Guanajuato Silver
GSilver is a precious metals producer engaged in reactivating past producing silver and gold mines in central Mexico. The Company produces silver and gold concentrates from the El Cubo Mine Complex, Valenciana Mines Complex, and the San Ignacio mine; all three mines are located within the state of Guanajuato, which has an established 480-year mining history. In addition, the Company produces silver, gold, lead, and zinc concentrates from the Topia mine in northwestern Durango. With four operating mines and three processing facilities, Guanajuato Silver is one of the fastest growing silver producers in Mexico.

Technical Information
Hernan Dorado Smith (Qualified Professional – MMSA), a director and officer of GSilver and a "qualified person" as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects, has approved the scientific and technical information contained in this news release.

ON BEHALF OF THE BOARD OF DIRECTORS
"James Anderson"
Chairman and CEO

For further information regarding Guanajuato Silver Company Ltd., please contact:

JJ Jennex, Gerente de Comunicaciones, T: 604 723 1433
E: jjj@GSilver.com
Gsilver.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains certain forward-looking statements and information, which relate to future events or future performance including, but not limited to, the benefit from the agreement announced in this press release, expansion of silver production in the Guanajuato area through the processing of low-cost and readily available material, unutilized capacity still available at El Cubo, the pursuit of similar business agreements with other mining groups in the area, the amount of tonnes of additional material to be processed at the El Cubo mill on a monthly basis, the expected timeline to generate the first silver and gold concentrates from this processing agreement, and the Company’s status as one of the fastest growing silver producers in Mexico.

Such forward-looking statements and information reflect management’s current beliefs and expectations and are based on information currently available to and assumptions made by the Company; which assumptions, while considered reasonable by the Company, are inherently subject to significant operational, business, economic and regulatory uncertainties and contingencies. These assumptions include: our estimates of mineral resources and other mineralized material at El Cubo and the Company’s other mining projects in Guanajuato, Mexico and the assumptions upon which they are based, including geotechnical and metallurgical characteristics of rock conforming to sampled results and metallurgical performance; available tonnage of mineralized material to be mined and processed; resource grades and recoveries; assumptions and discount rates being appropriately applied to the 2023 Preliminary Economic Assessment on El Cubo ("2023 PEA"); the ability of the Company to ramp up processing of mineral resources and material at El Cubo and the Company’s other mining projects at the projected rates and source sufficient high grade mineralized material to fill such processing capacity; prices for silver, gold and other metals remaining as estimated; currency exchange rates remaining as estimated; availability of funds for the Company’s projects and to satisfy current liabilities and obligations including debt repayments; capital cost estimates; operating costs; decommissioning and reclamation estimates; prices for energy inputs, labour, materials, supplies and services (including transportation) and inflation rates remaining as estimated; no labour-related disruptions; no unplanned delays or interruptions in scheduled construction and production; all necessary permits, licenses and regulatory approvals are received in a timely manner; and the ability to comply with environmental, health and safety laws. The foregoing list of assumptions is not exhaustive.

Readers are cautioned that such forward-looking statements and information are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results, level of activity, production levels, performance or achievements of GSilver to differ materially from those expected including, but not limited to, market conditions, availability of financing, future prices of gold, silver and other metals, currency rate fluctuations, high inflation and interest rates, actual results of production, exploration and development activities, actual resource grades and recoveries of silver, gold and other metals, availability of third party mineralized material for processing, unanticipated geological or structural formations and characteristics, geopolitical conflicts including wars, environmental risks, operating risks, accidents, labor issues, equipment or personnel delays, delays in obtaining governmental or regulatory approvals and permits, inadequate insurance, and other risks in the mining industry. There are no assurances that GSilver will be able to successfully discover and mine sufficient quantities of high grade mineral resources or other material at El Cubo, VMC, San Ignacio and Topia (including at Topia buying and processing ore from contractors) for processing at its existing mills to increase production, tonnage milled and recovery rates of gold, silver, and other metals in the amounts, grades, recoveries, costs and timetable anticipated. In addition, GSilver’s decision to process mineral resources and other material from El Cubo, VMC, San Ignacio and Topia is not based on a feasibility study of mineral reserves demonstrating economic and technical viability and therefore is subject to increased uncertainty and risk of failure, both economically and technically. Mineral resources and mineralized material that are not mineral reserves do not have demonstrated economic viability, are considered too speculative geologically to have economic considerations applied to them, and may be materially affected by environmental, permitting, legal, title, socio-political, marketing, and other relevant issues. There are no assurances that the Company’s projected production of silver, gold and other metals or the 2023 PEA will be realized. In addition, there are no assurances that the Company will meet its production forecasts or generate the anticipated cash flows from operations to satisfy its scheduled debt payments or other liabilities when due or meet financial covenants to which the Company is subject or to fund its exploration programs and corporate initiatives as planned. There is also uncertainty about the continued spread and severity of COVID-19, the ongoing war in Ukraine and high inflation and interest rates and the impact they will have on the Company’s operations, supply chains, ability to access mining projects or procure equipment, supplies, contractors and other personnel on a timely basis or at all and economic activity in general. Accordingly, readers should not place undue reliance on forward-looking statements or information. All forward-looking statements and information made in this news release are qualified by these cautionary statements and those in our continuous disclosure filings available on SEDAR at www.sedar.com including the Company’s most recently filed annual information form. These forward-looking statements and information are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required by law.

SOURCE: Guanajuato Silver Company Ltd.

View the original press release on accesswire.com

SAN JOSE, CA / ACCESSWIRE / January 17, 2024 / Avidbank Holdings, Inc. (OTC PINK:AVBH), a bank holding company and the parent company of Avidbank, is pleased to announce that James Deutsch has joined the Board of Directors. Mr. Deutsch brings over 40 years of banking experience to the Board.

Mr. Deutsch will be replacing Mr. Roxy Rapp who retired as a longstanding director on Avidbank’s Board at the end of 2023.

"First, I want to thank Roxy for his 17 years of commitment and service to our board. Roxy has contributed on so many levels in so many different situations over the years. His real estate expertise, network, as well as his financial commitment have been invaluable in our progress. Roxy’s presence, insight and constructive personality will be missed in our boardroom. At the same time, we are looking forward to Jim’s contributions to the board," noted Mark Mordell, Chairman and Chief Executive Officer.

Mr. Deutsch is a partner in Patriot Financial Partners, a private equity firm based in Radnor, Pennsylvania. Prior to joining Patriot in 2021, Mr. Deutsch served as President, CEO, and Founder of Team Capital Bank, a privately held institution headquartered in Bethlehem, Pennsylvania. Before Team Capital, he spent over 25 years with Commerce Bank, Brown Brothers Harriman, and Summit Bank. At those banks, he held various management positions in commercial banking, investment banking, and corporate finance.

At Patriot, Mr. Deutsch is a member of the Investment Committee, and he also has responsibility for new investment opportunities. He has served on the Board of Directors of more than 10 banks ranging in size from $1 billion to $30 billion in assets. Outside of Patriot, Mr. Deutsch has served on the boards of many not-for-profit agencies and served as Chair on several of those including the State Theatre, Valley Youth House, and Minsi Trails Boy Scouts. Mr. Deutsch received his BS in Finance and his MBA from Lehigh University.

"We are pleased to welcome Jim to our board. For years, Jim and his firm have been one of our most significant and supportive investors. His operational experience will be accretive to our board and mission," said Mr. Mordell.

"I am pleased and honored to be joining the other directors on the board of Avidbank. The management of Avidbank has done a great job of building a unique franchise and I look forward to doing what I can to assist and execute on their future growth strategies," Mr. Deutsch stated.

In other board news, Ms. Henchy Enden has resigned from the board due to internal requirements of a new position she has recently taken with a global investment management firm.

"I am disappointed that Henchy had to resign after such a short tenure on our board. She has been a great asset to us over the past eighteen months. That being said, I fully understand her situation and am in support of her and her future endeavors. I thank Henchy for her contribution and wish her the very best in her new role," said Mr. Mordell.

About Avidbank

Avidbank Holdings, Inc. (OTC PINK:AVBH), headquartered in San Jose, California, offers innovative financial solutions and services. We specialize in commercial & industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, fund finance, and real estate construction and commercial real estate lending. Avidbank provides a different approach to banking. We do what we say.

Contact:

Patrick Oakes
Executive Vice President and Chief Financial Officer
408-200-7390
IR@avidbank.com

SOURCE: Avidbank Holdings, Inc.

View the original press release on accesswire.com

• UTILITY has received a Prescription Drug User Fee Act (PDUFA) target action date of April 24, 2024
• FDA granted Qualified Infectious Disease Product (QIDP) designation for PIVYA in 2018, which provides an additional 5 years of data exclusivity upon approval

LONDON, UK / ACCESSWIRE / January 17, 2024 / UTILITY therapeutics Ltd., a biotechnology company focused on the development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTIs) in the U.S., today announced a private financing led by the AMR Action Fund. In addition, UTILITY announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for PIVYA (pivmecillinam) for the treatment of uncomplicated UTIs (uUTI).

The FDA granted Priority Review of the NDA with a Prescription Drug User Fee Act (PDUFA) target action date of April 24, 2024.

Pivmecillinam is a European-approved, oral prodrug of mecillinam. Pivmecillinam has a unique mechanism of action and targets penicillin binding protein-2 (PBP-2) in the cell wall of gram-negative bacteria. UTILITY has received the FDA’s qualified infectious disease product (QIDP) designation for pivmecillinam for the treatment of uUTI. The FDA’s QIDP designation is for antibacterial and antifungal drug candidates intended to treat serious or life-threatening infections, and it provides an additional five years of market exclusivity.

"The number of safe, effective antibiotics that clinicians have at their disposal continues to dwindle in the face of rising rates of antimicrobial resistance," said AMR Action Fund CEO Henry Skinner, PhD. "Bringing pivmecillinam to the U.S. will give clinicians an important tool to help patients suffering from urinary tract infections and support efforts to enhance global access to this drug."

"We are grateful to the AMR Action Fund for its leadership and support to bring this much-needed antibiotic to the US market for uUTI," said Tom Hadley, President and CEO of UTILITY therapeutics. "We believe that PIVYA can be utilized as a first-line therapy where many of the current therapeutic options are limited due to efficacy, safety, and/or rising rates of resistance. Given there has not been a new antibiotic approved in the U.S. for the treatment of uUTI in over 20 years, the priority review by the FDA for PIVYA is an important step to providing a new option to physicians and patients as antimicrobial resistance continues to rise."

"This unique mechanism leads to favorable stability against beta-lactamase hydrolysis compared to other penicillins. In more than 30 million courses of treatment administered across Europe, oral pivmecillinam has demonstrated strong clinical cure rates with no serious adverse events observed, while maintaining a low resistance rate of approximately 5%," said Professor Morten Sommer, co-founder of UTILITY.

About UTILITY therapeutics Ltd.

UTILITY has exclusive U.S. commercial rights to two European-approved antibiotics, pivmecillinam and mecillinam, for the treatment of urinary tract infections (UTI). Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases. Mecillinam, an intravenous (IV) formulation, is being developed as a first-line therapy for complicated UTI (cUTI) in the hospital setting.

UTILITY has received the FDA’s qualified infectious disease product (QIDP) designation for pivmecillinam for the treatment of uUTI, and IV mecillinam followed by oral pivmecillinam as step-down, carbapenem-sparing therapy for cUTI. This therapeutic regimen allows patients to complete their treatment outside of hospital and reduces the economic burden of cUTI to both patients and payers. The FDA’s QIDP designation is for antibacterial and antifungal drug candidates intended to treat serious or life-threatening infections, and provides an additional five years of market exclusivity and potentially includes Priority Review.

For additional information, please visit www.utilitytherapeutics.com.

Contact

Tom Hadley
Chief Executive Officer
Tel: +1 (973) 224-7272
info@utilitytherapeutics.com

SOURCE: Utility therapeutics Ltd.

View the original press release on accesswire.com

LOS ANGELES, CA / ACCESSWIRE / January 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against VNET Group, Inc. ("VNET" or "the Company") (NASDAQ:VNET) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between April 8, 2022 and February 15, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before February 26, 2024.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. GenTao Capital Limited ("GenTao") was experiencing financial difficulties that created a substantial risk that its creditors would acquire its significant overship stake in VNET. The Company would issue newly created shares to GenTao owner Josh Sheng Chen, diluting the shares owned by investors. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about VNET, investors suffered damages.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

View the original press release on accesswire.com

• Offer document published following approval by BaFin.
• Acceptance period commences today and ends on February 16, 2024; there will be no additional acceptance period.
• Opportunity for all CropEnergies shareholders to tender their shares at an attractive cash consideration of € 11.50 per share, representing a premium of around 36.9 % on the volume-weighted average price during the last six months preceding the publication of the decision to launch the delisting tender offer.
• Delisting tender offer is not subject to any closing conditions
• Delisting holds potential for improving liquidity and a revaluation of the Südzucker shares from which shareholders of CropEnergies can benefit through a re-investment in Südzucker.
• CropEnergies remains a strong independent pillar of the Südzucker Group.
• Executive board of CropEnergies supports delisting.

MANNHEIM, GERMANY / ACCESSWIRE / January 17, 2024 / Südzucker AG ("Südzucker") announces the publication of the offer document for the public delisting tender offer to all shareholders of CropEnergies AG ("CropEnergies") for the acquisition of all outstanding shares not already directly held by Südzucker, following the approval by the German Federal Financial Supervisory Authority ("BaFin"). Both companies signed a delisting agreement in this matter on December 19, 2023. Südzucker currently holds around 79.8 % of the share capital in CropEnergies.

The acceptance period begins today and ends at midnight (CET) on February 16, 2024.

CropEnergies shareholders can accept the delisting tender offer by tendering their shares at an offer price of € 11.50 per share. The offer price corresponds to a premium of approximately 36.9 % on the volume-weighted average price of the last six months preceding the publication of the decision to launch the delisting tender offer and a premium of around 69.4 % on the last Xetra® closing price of December 18, 2023, i.e. the closing price on the last day prior to the publication of the decision to launch the delisting tender offer.

CropEnergies shareholders who wish to accept the delisting tender offer must promptly contact their respective custodian bank or any other securities services company where their CropEnergies shares are being held. As announced on December 19, 2023, the delisting of CropEnergies is a logical step towards a more defined capital market profile of the Südzucker Group. The delisting creates additional potential for improving liquidity and a revaluation of the Südzucker shares. The delisting will enable CropEnergies to develop its strategic projects within the Südzucker Group with a focus on bio-based chemicals in a more focused manner. CropEnergies remains a strong independent pillar of the Südzucker Group.

The executive board of CropEnergies has undertaken, subject to customary reservations, to support a delisting and apply for revocation of the admission of all CropEnergies shares to trading on the regulated market of the Frankfurt Stock Exchange during the acceptance period. The executive board and supervisory board of CropEnergies will also publish a joint reasoned opinion on the delisting tender offer during the acceptance period.

Dr Niels Pörksen, CEO of Südzucker, says: "We would like to encourage all CropEnergies shareholders to accept our attractive offer before their shares are delisted from the regulated market. Shareholders of CropEnergies can also benefit from the future bundled value potential of the entire Südzucker-Group through a re-investment in Südzucker shares. The delisting will create capacities that we will utilise to accelerate the implementation of our ‘Strategy 2026 PLUS’. CropEnergies will increasingly focus on the growth topics of biobased chemicals."

The delisting tender offer will not be extended (unless required by law) and is not subject to any conditions. The delisting of the CropEnergies shares from the regulated market is expected to become effective after the expiry of the acceptance period of the delisting tender offer by the end of February 2024. The offer document and a non-binding English translation, alongside other information regarding the delisting tender offer, are available at www.powerofplants-offer.com. In addition, a shareholder hotline has been set up, which shareholders can call on 0080008250941 (inside Germany) or +44 207 2930434 (outside Germany, hosted in German) or +44 207 2930434 (outside Germany, hosted in English) if they have any questions.

Copies of the offer document are also available free of charge from the Delisting Acquisition Offer Settlement Agent: Deutsche Bank Aktiengesellschaft, TAS, Post-IPO Services, Taunusanlage 12, 60325 Frankfurt am Main, Germany. (Order for dispatch of the offer document by fax to +49 69 910 38794 or e-mail to dct.tender-offers@db.com, stating a complete postal address).

Important notice

This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of CropEnergies AG nor an offer or recommendation to purchase shares of Südzucker AG. The definitive terms of the delisting tender offer, as well as further provisions concerning the delisting tender offer, are set out in the offer document the publication of which has been approved by the German Federal Financial Supervisory Authority (BaFin). Investors and holders of shares in CropEnergies AG are strongly advised to read the offer document and all other relevant documents regarding the delisting tender offer, since they contain important information.

The delisting tender offer has been published exclusively under the laws of the Federal Republic of Germany, in particular in accordance with the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz) and the German Stock Exchange Act (Börsengesetz), as well as certain applicable provisions of the U.S. Securities Exchange Act. The documentation relating to the delisting tender offer is or will be available at www.powerofplants-offer.com. Any contract that is concluded on the basis of the delisting tender offer will be exclusively governed by the laws of the Federal Republic of Germany and is to be interpreted in accordance with such laws.

To the extent permissible under applicable law or regulation, and in accordance with German market practice, Südzucker AG, its affiliates or its brokers may purchase, or conclude agreements to purchase, shares of CropEnergies AG, directly or indirectly, outside of the scope of the delisting tender offer during or after the period in which the offer remains open for acceptance. This also applies to other securities which are directly convertible into, exchangeable for, or exercisable for shares of CropEnergies AG. These purchases may be completed via the stock exchange at market prices or outside the stock exchange at negotiated conditions. Any information on such purchases will be disclosed as required by law or regulation in Germany or any other relevant jurisdiction and on www.powerofplants-offer.com.

Südzucker AG
Maximilianstraße 10
68165 Mannheim, Germany

Financial press:

Dr Dominik Risser
Phone: +49 621 421-205
public.relations@suedzucker.de

Investor Relations:

Nikolai Baltruschat
Phone: +49 621 421-240
investor.relations@suedzucker.de

About the Südzucker Group

Südzucker is a major player in the food industry with its sugar, special products, starch and fruit segments, and Europe’s leading ethanol producer with its CropEnergies segment.

In the traditional sugar business, the group is Europe’s number one supplier of sugar products, with 23 sugar factories and two refineries, extending from France in the west via Belgium, Germany and Austria, through to Poland, the Czech Republic, Slovakia, Romania, Hungary, Bosnia, and Moldova in the east. The special products segment, with its consumer-oriented functional ingredients for food and animal feed (BENEO), chilled/frozen products (Freiberger) and portion packs (PortionPack Group), operates in dynamic growth markets. Südzucker’s CropEnergies segment is Europe’s leading producer of renewable ethanol, with production sites in Germany, Belgium, France and Great Britain. Other products in this segment are protein food and animal feed products as well as biogenic carbon dioxide. The starch segment comprises AGRANA’s starch and ethanol activities. The group’s fruit segment operates globally, is the world market leader for fruit preparations and is a leading supplier of fruit juice concentrates in Europe.

In 2022/23, the group employed about 18.300 persons and generated revenues of about EUR 9.5 billion.

About the CropEnergies AG

Sustainable, renewable products made from biomass – that is what CropEnergies stands for. Our products contribute to a climate-friendly world and ensure that fossil carbons remain in the ground permanently and do not continue to drive climate change.

Founded in Mannheim in 2006, the member of the Südzucker Group is the leading European producer of renewable ethanol. With a production capacity of 1.3 million m³ of ethanol per year, CropEnergies produces neutral alcohol as well as technical alcohol (ethanol) for a wide range of applications at locations in Germany, Belgium, the UK, and France: Sustainably produced ethanol as a petrol substitute is an answer to the future challenges of climate-friendly energy supply in the transport sector. Thanks to highly efficient production plants, our ethanol reduces CO₂ emissions by an average of more than 70 percent across the entire value chain compared to fossil fuel. Our high-quality alcohol is also used in beverage production, cosmetics, pharmaceutical applications, for example as a basis for disinfectants, or as a raw material for innovative biochemicals.

Equally important are the resulting protein food and animal feed products as a sustainable regional alternative to emission-intensive protein imports from overseas, as well as biogenic carbon dioxide. It is used in beverage production, among other things, and will be a valuable raw material for a wide range of applications in transport and industry in the future. Thus, all raw material components are utilised in our circular economy.

SOURCE: Südzucker AG

View the original press release on accesswire.com